---
title: "Thinking more deeply about external validity"
description: "A critical look at applying the results of randomized controlled trials (RCTs) from specialized settings to general critical care practice."
date: 2025-11-14
tags: 
  - methodology
  - research
  - critical-care
---

The goal of any well-designed Randomized Controlled Trial (RCT) is to establish **internal validity**â€”the certainty that the observed effect is truly due to the intervention. However, for the busy critical care clinician, the more pressing question is: **does this apply to *my* patient, in *my* ICU?** This is the core question of **external validity**, or generalizability.

In Critical Care Medicine, external validity is notoriously challenging. Trials often employ strict inclusion and exclusion criteria to isolate a signal, frequently leading to a study cohort that is healthier or more homogenous than the typical mixed bag of pathology seen in an average intensive care unit.

***

## Bridging the Gap: From Trial to Bedside

When reading a new trial, the critical step is to consciously evaluate how far the findings can be extrapolated from the rarefied air of the study's **academic setting** to the diverse, real-world context of your practice.

### Key Factors to Consider for Generalizability

To truly interrogate a trial's external validity, consider the following:

* **Patient Characteristics (P in PICO)**: Were the patients significantly different from your typical cohort in terms of age, severity of illness (e.g., SOFA score), or key comorbidities? If a trial in sepsis excluded patients with chronic liver failure, its generalizability to a patient *with* liver failure is immediately limited.
* **Intervention Fidelity and Logistics (I in PICO)**: Could your unit feasibly replicate the intervention as performed in the trial? Some interventions rely on expensive, proprietary equipment or require **highly specialized nursing or physician expertise** that may not be available outside of a handful of tertiary centers.
* **Study Site Setting**: Was the study conducted exclusively in **high-volume academic ICUs**? These environments often have better staffing ratios and faster diagnostic turnaround times. Results from these settings might not be achievable in a smaller community hospital or a lower-resource system.
* **Comparator (C in PICO)**: Was the "standard care" in the control group truly representative of the **current standard of care** at your institution and beyond? An older control arm can make a new intervention look better than it would against modern best practices.

***

Ultimately, the most important tool for assessing external validity is the **reader's clinical judgment**. Do not outsource this responsibility to the authors. Instead, use their excellent work on internal validity as a starting point, and then act as the bridge, thoughtfully determining whether the evidence translates into improved care for the patients under your charge.